The mood across global markets is not great at this point of time. News headlines point in directions we would rather they did not. But suc...

Why is the stock market down today? A hotter-than-expected jobs report erased any lingering hope for near-term Federal Reserve rate cuts — ...

India is currently sidelined from the global AI investment boom due to its lack of semiconductor manufacturing. While the Indian IT sector ...

India's central bank, the RBI, confronts a new inflation challenge. Rising oil prices and supply disruptions threaten to undo recent progre...

Indian markets traded cautiously on Thursday's weekly expiry, with analysts observing a continued tussle for direction in the Nifty. Key co...

India is looking to boost foreign investment by reforming its tax system. Recent proposals aim to simplify taxes on foreign holdings. The c...

Amit Khurana of Dolat Capital has upgraded India's IT sector, citing depressed valuations and rupee depreciation as key drivers. He believe...

American investor Vanguard has sharply cut the fair value of Ola's parent company. This and more in today's ETtech Top 5.

India is set to eliminate capital gains tax for foreign portfolio investors on government securities to boost overseas capital inflows. Thi...

Initial fears of an "SaaSpocalypse" following Anthropic's AI plug-in release have subsided. Brokerages now suggest AI is driving a shift to...

Wockhardt shares dropped after a recent surge, as investors took profits. This followed the US FDA approval of ZAYNICH, an antibiotic for u...

Wockhardt's novel antibiotic, Zaynich, has received USFDA approval after a 12-year effort, sparking hopes for a turnaround after years of n...

Indian equities face a mixed outlook due to potential monsoon deficit and uneven corporate earnings. While rural-linked sectors may see pre...

Wockhardt's shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections....

Equity mutual funds saw strong performance in May, with returns reaching up to 17%. International funds led the gains, driven by markets li...

Prime Focus shares saw a rise on Friday. The company reported a profit of Rs 82 crore for the fourth quarter of FY26. This marks a signific...

Wockhardt Ltd has secured approval from the CDSCO for its new antibiotic, Zaynich. This drug is developed in India and will be used to trea...